Search Results - "BASSISSI, Firas"

Refine Results
  1. 1

    Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification by Perelló, Joan, Alberti, Joan, Torres, Juan Vicente, Ferrer, Miguel D, Perez, M Mar, Bassissi, Firas, Gold, Alex, Raggi, Paolo, Chertow, Glenn M, Salcedo, Carolina

    Published in Frontiers in pharmacology (07-02-2024)
    “…Patients receiving dialysis have high cardiovascular risk in part due to extensive vascular calcification. In the CaLIPSO study, infusion of hexasodium fytate…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Breed differences in the pharmacokinetics of ivermectin administered subcutaneously to Holstein and Belgian Blue calves by Vercruysse, Jozef, Deprez, Piet, Everaert, Dries, Bassissi, Firas, Alvinerie, Michel

    Published in Veterinary parasitology (25-03-2008)
    “…Belgian Blue (BB) cattle are very sensitive to mange caused by Psoroptes ovis and, in contrast to the case in Holstein cattle, single treatments with…”
    Get full text
    Journal Article
  4. 4

    Influence of dyslipidemia on moxidectin distribution in plasma lipoproteins and on its pharmacokinetics by FIRAS BASSISSI, Mohamad, ALVINERIE, Michel, MARTIN, Pascal Guy Pierre, FERRET, Bertrand, LESPINE, Anne

    Published in Pharmaceutical research (01-11-2006)
    “…We studied the influence of dyslipemia on the distribution of moxidectin, a potent antiparasitic drug of the macrocyclic lactone (ML) family, in plasma…”
    Get full text
    Journal Article
  5. 5

    The FIPO23 trial: First-in-human phase I/II study of XON7 in advanced solids tumors by Bennouna, Jaafar, Shneiker, Françoise, BLAY, Jean Yves, Awada, Ahmad, Bassissi, Firas, Ratta, Raffaele, Delord, Jean-Pierre

    Published in Journal of clinical oncology (01-06-2024)
    “…TPS2673 Background: XON7 is a first-in-class glyco-humanized polyclonal antibody (GH-pAb) targeting selectively multiple tumor-associated antigens. XON7…”
    Get full text
    Journal Article
  6. 6

    Macrocyclic lactones: distribution in plasma lipoproteins of several animal species including humans by Bassissi, Mohamad Firas, Alvinerie, Michel, Lespine, Anne

    “…We studied the in vitro distribution of macrocyclic lactones (MLs), lipophilic anthelmintic drugs, in the plasma of several animal species including humans…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Abstract 2739: XON27, a novel and potent immunotherapy against hematologic malignancies by Ciron, Carine, Morice, Pierre, Shneiker, Françoise, Duvaux, Odile, Bassissi, Firas

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Background: Over the past decades, intensive research has led to the development of innovative therapies (monoclonal and bispecific antibodies, CAR T cells)…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration by Bassissi, Firas, Lespine, Anne, Alvinerie, Michel

    Published in Parasitology research (1987) (01-02-2006)
    “…Ivermectin is a member of the macrocyclic lactone family widely used in livestock, pets, and humans as a potent parasiticide. Slight differences in formulation…”
    Get full text
    Journal Article
  12. 12

    Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogs by Lespine, Anne, Chanoit, Guillaume, Bousquet-Melou, Alain, Lallemand, Elodie, Bassissi, Firas Mohamad, Alvinerie, Michel, Toutain, Pierre-Louis

    “…Moxidectin, a macrocyclic lactone (ML), is a potent parasiticide widely used in veterinary medicine and currently under development for use in humans. The…”
    Get full text
    Journal Article
  13. 13

    P1234SNF472 IMPROVES LIMB BLOOD PERFUSION AND WALKING ABILITY IN A PERIPHERAL ARTERY DISEASE VASCULAR CALCIFICATION RAT MODEL by Bassissi, Firas, Ferrer Reynes, Miguel David, Pérez, M Mar, Perelló, Joan, Salcedo, Carolina

    Published in Nephrology, dialysis, transplantation (01-06-2020)
    “…Abstract Background and Aims Peripheral Artery disease (PAD) is a common vascular disease associated with functional impairment and increased risk of…”
    Get full text
    Journal Article
  14. 14

    P0884MYO-INOSITOL HEXAPHOSPHATE PEGYLATION IMPROVES BIOAVAILABILITY BUT REDUCES ITS ANTI-VASCULAR CALCIFICATION EFFECT IN RATS by Pérez, M Mar, Ferrer Reynes, Miguel David, Ortega-Castro, Joaquín, Bassissi, Firas, Perelló, Joan, Salcedo, Carolina

    Published in Nephrology, dialysis, transplantation (01-06-2020)
    “…Abstract Background and Aims Vascular calcification (VC) is a major contributor to increased morbidity and mortality in End Stage Kidney Disease (ESKD)…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma by Brun, Sonia, Bassissi, Firas, Serdjebi, Cindy, Novello, Marie, Tracz, Jennifer, Autelitano, François, Guillemot, Marie, Fabre, Philippe, Courcambeck, Jérôme, Ansaldi, Christelle, Raymond, Eric, Halfon, Philipe

    Published in Investigational new drugs (01-12-2019)
    “…Summary Among the acquired modifications in cancer cells, changes in lysosomal phenotype and functions are well described, making lysosomes a potential target…”
    Get full text
    Journal Article
  18. 18

    Clinical significance of high expression of a specific solute carrier transporter in HCC by Gifu, Patricia, Brun, Sonia, Wang, Guanxiong, Bassissi, Firas, Caron de Fromentel, Claude, Merle, Philippe, Halfon, Philippe

    Published in Journal of clinical oncology (01-02-2018)
    “…Abstract only 303 Background: Hepatocellular carcinoma (HCC) is the third cause of cancer-related death. GNS561 (Genoscience Pharma, France) is a small…”
    Get full text
    Journal Article
  19. 19

    Enhancement of oral moxidectin bioavailability in rabbits by lipid co-administration by FIRAS BASSISSI, Mohamad, LESPINE, Anne, ALVINERIE, Michel

    Published in Parasitology research (1987) (01-10-2004)
    “…Moxidectin is a member of the macrocyclic lactone family of drugs widely used for the control of internal and external parasites. Because moxidectin is highly…”
    Get full text
    Journal Article
  20. 20

    Abstract 2737: LIS22, a first in class polyclonal antibody immunotherapy in T cell blood cancers by Ciron, Carine, Shneiker, Francoise, Dauphouy, Ophélie, Rousse, Juliette, Royer, Pierre-Joseph, Evanno, Gwenaelle, Duvaux, Odile, Bassissi, Firas

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Background: Several approaches such as antibody drug conjugate (ADC), chimeric antigen receptor T cells (CAR-T) and recently bispecific antibodies are being…”
    Get full text
    Journal Article